Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 70518-1749

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-1749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 01

Chemical structure of divalproex sodium, showing its molecular formula with sodium ions and organic groups. The structure is displayed in a black-and-white line diagram format typical for chemical illustrations.*

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 02

A line graph displaying the percentage reduction in CPS (Clinical Parameter Score) rate versus the percentage of patients for Divalproex Sodium delayed-release tablets compared to placebo. The solid line represents Divalproex Sodium, showing greater improvement over placebo, which is indicated by the dashed line. The vertical axis measures percentage reduction in CPS rate, ranging from -100% to 100%, with improvement and worsening directions labeled, while the horizontal axis shows the percentage of patients from 0 to 100.*

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 03

This is a line graph depicting the percentage reduction in CPS rate on the vertical axis versus the percentage of patients on the horizontal axis. Two dose groups, High Dose (solid line) and Low Dose (dashed line), are compared. The vertical axis ranges from -100% (worsening) to 100% (improvement), with a midline at 0% indicating no change. The horizontal axis shows patient percentages from 100% to 0%.*

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 04

An instructional diagram showing how to open a large coated pellet capsule, separate and empty the capsule contents onto a small amount of soft food like applesauce or pudding, and instructions to swallow the mixture immediately without chewing. Four steps with accompanying images illustrate careful handling to avoid spilling pellets and advice on mixing and consuming the sprinkle and food mixture.*

FDA Label Image

Divalproex Sodium 125mg 70518 1749 00

Label for Divalproex Sodium 125 mg delayed-release sprinkle capsule, quantity 1, repackaged by RemedyRepack Inc. It includes the NDC number 70518-1749-00 and manufacturer Zydus Pharm, Pennington, NJ. Directions reference the package insert, with storage temperature guidance provided.*

FDA Label Image

Remedy_label (Remedy Label)

Label for divalproex sodium delayed-release capsules, 125 mg strength, in a quantity of 100 capsules. The label indicates the product is for oral use with a sprinkle formulation. Manufactured by Zydus Pharm, repackaged by RemedyRepack Inc. Includes NDC 70518-1749-01 and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.